Health Products

Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products - Drugs
Product: Jamp-Atorvastatin 40 mg tablets (lot MHC1403A, expiry 2023-09-30)
Issue: Health products - Contamination
What to do: Contact your pharmacy to confirm if you are taking medication from the affected lot. If you are, stop taking it and return it to your pharmacy for a replacement product and proper disposal.
Audience: General public
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

LotDINProductExpiry
MHC1403A02391074Jamp-Atorvastatin 40 mg tablets2023-09-30

Issue

Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.

Atorvastatin is a prescription drug used to treat high cholesterol and other fats (such as triglycerides) in the blood, and to prevent cardiovascular disease such as heart attacks.

Ingesting latex can pose serious health risks for people with latex allergies, including severe allergic reactions (anaphylaxis). Symptoms of anaphylaxis include breathing difficulties, nausea, vomiting, and low blood pressure. Anaphylaxis can be life threatening. In addition, foreign material in the tablets may change their shape, which could make them difficult to swallow and lead to choking.

The Department is monitoring the company’s recall and will inform Canadians if any new health risks are identified.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime